Search research articles
Contact Us
Filters
Showing results (181-190 of 205) with videos related to
Page
of 21
Sort By:
Oncogene
|
June 30, 2015
Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer
Y-W Chang, C-F Tseng, M-Y Wang, et al.
Oncogene
|
September 21, 2019
Correction: Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer
Y W Chang, C F Tseng, M Y Wang, et al.
Oncogene
|
July 22, 1998
Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties
L Zhang, Y K Lau, L Xi, et al.
Cancer Gene Therapy
|
March 4, 2006
Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model
C-P Day, K-M Rau, L Qiu, et al.
Nature Medicine
|
February 2, 2000
The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis
X Xing, S C Wang, W Xia, et al.
Oncogene
|
December 17, 2009
NF-kappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx
T M Bui-Nguyen, S B Pakala, R D Sirigiri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2000
Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members
W Xia, Y K Lau, H Z Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2000
E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway
N T Ueno, C Bartholomeusz, J L Herrmann, et al.
Oncogene
|
May 8, 2012
Targeted endostatin-cytosine deaminase fusion gene therapy plus 5-fluorocytosine suppresses ovarian tumor growth
Y-P Sher, C-M Chang, C-G Juo, et al.
Oncogene
|
May 19, 2009
Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation
Y Liao, Y Wei, X Zhou, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 205) with videos related to
Sort By:
Page
of 21
Oncogene
|
June 30, 2015
Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer
Y-W Chang, C-F Tseng, M-Y Wang, et al.
Oncogene
|
September 21, 2019
Correction: Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer
Y W Chang, C F Tseng, M Y Wang, et al.
Oncogene
|
July 22, 1998
Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties
L Zhang, Y K Lau, L Xi, et al.
Cancer Gene Therapy
|
March 4, 2006
Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model
C-P Day, K-M Rau, L Qiu, et al.
Nature Medicine
|
February 2, 2000
The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis
X Xing, S C Wang, W Xia, et al.
Oncogene
|
December 17, 2009
NF-kappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx
T M Bui-Nguyen, S B Pakala, R D Sirigiri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2000
Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members
W Xia, Y K Lau, H Z Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2000
E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway
N T Ueno, C Bartholomeusz, J L Herrmann, et al.
Oncogene
|
May 8, 2012
Targeted endostatin-cytosine deaminase fusion gene therapy plus 5-fluorocytosine suppresses ovarian tumor growth
Y-P Sher, C-M Chang, C-G Juo, et al.
Oncogene
|
May 19, 2009
Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation
Y Liao, Y Wei, X Zhou, et al.
Page
of 21